Trademark: 88446352
Status Date
Monday, September 13, 2021
Filing Date
Friday, May 24, 2019
Published for Opposition
Tuesday, September 24, 2019
5 Allergy medications; Homeopathic pharmaceuticals for use in the treatment of dry eye; Medical preparations for the treatment of dry eye; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment and prevention of dry eye; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of dry eye; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Plant and herb extracts sold as components of medicated cosmetics; Drug delivery agents in the form of dry eye that facilitate the delivery of pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparation for skin care; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for treating allergies; Pharmaceutical products for ophthalmological use
Sep 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 12, 2021
Sou Extension 3 Granted
May 19, 2021
Sou Extension 3 Filed
Aug 25, 2021
Teas/Email Correspondence Entered
Aug 25, 2021
Correspondence Received In Law Office
Aug 24, 2021
Notice Of Revival - E-Mailed
Aug 24, 2021
Petition Granted - Response Received
Jul 22, 2021
Teas Response To Petition Deficiency Received
Jun 30, 2020
Petition Inquiry Letter Issued
Jun 29, 2021
Assigned To Petition Staff
Jun 18, 2021
Teas Petition To Director Received
May 28, 2021
Examiner's Amendment Entered
May 27, 2021
Notification Of Examiners Amendment E-Mailed
May 27, 2021
Examiners Amendment E-Mailed
May 27, 2021
Su-Examiner's Amendment Written
Nov 12, 2020
Notification Of Non-Final Action E-Mailed
Nov 12, 2020
Non-Final Action E-Mailed
Nov 12, 2020
Su - Non-Final Action - Written
Oct 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2020
Statement Of Use Processing Complete
Oct 15, 2020
Use Amendment Filed
Oct 21, 2020
Sou Extension 2 Granted
Oct 15, 2020
Sou Extension 2 Filed
Oct 15, 2020
Sou Teas Extension Received
Aug 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2020
Sou Extension 1 Granted
May 19, 2020
Sou Extension 1 Filed
Aug 17, 2020
Case Assigned To Intent To Use Paralegal
Jun 23, 2020
Notice Of Revival - E-Mailed
Jun 22, 2020
Sou Extension Received With Teas Petition
Jun 22, 2020
Petition To Revive-Granted
Jun 22, 2020
Teas Petition To Revive Received
Jun 22, 2020
Teas Statement Of Use Received
Jun 22, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 22, 2020
Abandonment - No Use Statement Filed
Nov 19, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 24, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 24, 2019
Published For Opposition
Sep 4, 2019
Notification Of Notice Of Publication E-Mailed
Aug 16, 2019
Approved For Pub - Principal Register
Aug 15, 2019
Examiner's Amendment Entered
Aug 15, 2019
Assigned To Lie
Aug 14, 2019
Notification Of Examiners Amendment E-Mailed
Aug 14, 2019
Examiners Amendment E-Mailed
Aug 14, 2019
Examiners Amendment -Written
Aug 13, 2019
Assigned To Examiner
Jun 11, 2019
New Application Office Supplied Data Entered
May 28, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
